ICOS and melanoma: The reasons for lack of response to IL-2 are starting to emerge: a recent study found that the T cell subset most induced by IL-2 in melanoma patients is regulatory T cells (Treg) expressing positive for CD4, CD25, Foxp3 and the inducible T cell costimulator (ICOS).